Tamer I. Khayal - May 1, 2024 Form 4/A Insider Report for TransMedics Group, Inc. (TMDX)

Signature
By: /s/ Stephen Gordon, Attorney-in-Fact
Stock symbol
TMDX
Transactions as of
May 1, 2024
Transactions value $
-$6,866,104
Form type
4/A
Date filed
5/14/2024, 06:00 PM
Date Of Original Report
May 3, 2024
Previous filing
Apr 10, 2024
Next filing
May 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Sale -$1.58M -14.9K -20.33% $106.25 58.2K May 1, 2024 Direct F1, F2
transaction TMDX Common Stock Sale -$1.26M -11.8K -20.26% $107.20 46.4K May 1, 2024 Direct F1, F3
transaction TMDX Common Stock Sale -$194K -1.79K -3.86% $108.35 44.6K May 1, 2024 Direct F1, F4
transaction TMDX Common Stock Sale -$1.43M -13.1K -29.31% $109.68 31.5K May 1, 2024 Direct F1, F5
transaction TMDX Common Stock Sale -$584K -5.31K -16.85% $110.00 26.2K May 1, 2024 Direct F1, F6
transaction TMDX Common Stock Sale -$11.3K -100 -0.38% $113.16 26.1K May 1, 2024 Direct F1
transaction TMDX Common Stock Sale -$38.1K -326 -1.25% $116.80 25.8K May 1, 2024 Direct F1, F7
transaction TMDX Common Stock Sale -$89.5K -759 -2.94% $117.97 25K May 1, 2024 Direct F1, F8
transaction TMDX Common Stock Sale -$169K -1.42K -5.66% $119.00 23.6K May 1, 2024 Direct F1, F9
transaction TMDX Common Stock Sale -$218K -1.82K -7.68% $119.96 21.8K May 1, 2024 Direct F1, F10
transaction TMDX Common Stock Sale -$51.2K -422 -1.93% $121.21 21.4K May 1, 2024 Direct F1, F11
transaction TMDX Common Stock Sale -$54.1K -444 -2.08% $121.84 20.9K May 1, 2024 Direct F1, F12
transaction TMDX Common Stock Sale -$12.4K -100 -0.48% $123.66 20.8K May 1, 2024 Direct F1, F13
transaction TMDX Common Stock Sale -$1.17M -11.1K -100% $105.71 0 May 1, 2024 By the Tamer Ibrahim Ahmed Khayal Trust F1, F14
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $105.89 to $106.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $106.885 to $107.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $107.89 to $108.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F5 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $109.00 to $109.855, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F6 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $110.00 to $110.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F7 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $116.32 to $117.155, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F8 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $117.46 to $118.425, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F9 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $118.51 to $119.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F10 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $119.51 to $120.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F11 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $120.52 to $121.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F12 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $121.515 to $122.505, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F13 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $123.64 to $123.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F14 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $105.50 to $105.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Remarks:

This amended Form 4 corrects a clerical error in the Form 4 filed by the Reporting Person on May 3, 2024, which incorrectly reported that 11,051 of the shares of the Issuer's Common Stock sold by the Reporting Person on May 1, 2024 were shares held directly by the Reporting Person prior to such disposition. This amended Form 4 corrects the Form 4 to report that 11,051 of the shares of the Issuer's Common Stock that were sold on May 1, 2024 were sold by the Tamer Ibrahim Ahmed Khayal Trust.